CN102327315A - Drug combination containing astragalus and use thereof - Google Patents
Drug combination containing astragalus and use thereof Download PDFInfo
- Publication number
- CN102327315A CN102327315A CN201110297559A CN201110297559A CN102327315A CN 102327315 A CN102327315 A CN 102327315A CN 201110297559 A CN201110297559 A CN 201110297559A CN 201110297559 A CN201110297559 A CN 201110297559A CN 102327315 A CN102327315 A CN 102327315A
- Authority
- CN
- China
- Prior art keywords
- drug combination
- astragalus
- radix astragali
- parts
- combination
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a drug combination containing astragalus and a use thereof. The drug combination contains astragalus or an astragalus extractive or a derivative thereof capable of being received chemically. The drug combination comprises the following components: 100 parts of astragalus and 1-50 of levamisole hydrochloride. On the basis, the following one or more components can be increased, but not limited: 20-150 parts of vitamin C. The use method and the dosage of the combination are shown as follows: a solid preparation is used after being mixed by 0.1-10.0 percent of complete feeds; and a liquid preparation is drunk after the water of 250-500 kg is added in the liquid preparation of 100 ml. The combination has the main function of inducing a human body to generate the interferon, promoting the antibody formation and adjusting the immunologic function of the human body. The drug combination is used for simulating an immune system of an animal body, adjusting the immunity, enhancing the disease resistance, reducing the disease incidence and assisting to treat the virus infection.
Description
Technical field
The present invention relates to a kind of medical composition and its use that contains the Radix Astragali and belong to animal Chinese medicine health care product field in the herding industry; Pharmaceutical composition is mainly used in stimulates the animal body immune system, regulates immunity, strengthens premunition; Reduce sickness rate, and the auxiliary treatment of viral infection.
Background technology
Along with expanding economy, living standard improves, and people are increasing to the demand of animal food, and food safety and prescription are also increasingly high.This provides more market to livestock-raising, also has higher requirement.Current, China's livestock-raising scale is enlarging, and cultivation density is increasing, and the animal sickness rate is also increasing thereupon, and kinds of Diseases are more and more, and the state of an illness also becomes increasingly complex.In order to reduce morbidity, many breeding enterprises have to use a large amount of chemicalses to carry out disease prevention, but this mode is brought another kind of hidden danger, and that is exactly the threat of drug residue to food safety.
In this case, use Chinese medicine to stimulate animal immune system, regulate immunity of organisms, strengthen premunition, reduce morbidity, reduce the clinical use amount of chemicals, guarantee animal food safety, a kind of more effective prevention and control mode of can yet be regarded as.Many like products are arranged on the current market, but production technology is coarse mostly, quality control is not tight, adulterates, and passes a fake product off as a genuine one, and curative effect can not be guaranteed.
This compositions processes through meticulous production technology; And select to detect astragaloside as the control of product quality link, and effectively avoid the interference of glucide, compatibility has the levamisole hydrochloride of immunoregulation effect simultaneously; Chinese and Western combines; The common immunity that promotes improves, and reduces sickness rate, increases economic efficiency.
Summary of the invention
A kind of medical composition and its use that contains the Radix Astragali that the present invention proposes is intended to Radix Astragali series products is transformed from aspects such as prescription, production technology, preparation formulations; Formulate new quality inspection standard simultaneously and come strict control product quality, to improve its clinical efficacy.
A kind of medical composition and its use that contains the Radix Astragali contains the derivant of the form of chemically can accepting of the Radix Astragali or Radix Astragali extract or Radix Astragali extract; The component and the prescription of compositions are: 100 parts of the Radixs Astragali, 1～50 part of levamisole hydrochloride.
Can increase as the case may be on this basis but be not limited to following one or more: 20～150 parts of vitamin Cs.
Compositions method for using according to the invention and use amount are: solid preparation uses later on by the mixed of complete feed 0.1～10.0%, and liquid preparation 100ml drinks after converting water 250kg～500kg, and the 1ml medicinal liquid is equivalent to the 1g raw medicinal herbs.
This compositions major function is to induce body to produce interferon, and enhancing antibody forms, and regulates body's immunity.Be used to stimulate the animal body immune system, regulate immunity, strengthen premunition, reduce sickness rate, and the auxiliary treatment of viral infection.
The Radix Astragali in the compositions is controlled its content through detecting astragaloside, can avoid the interference of glucose, more effectively controls product quality.
Embodiment 1: 45 parts of the Radixs Astragali.After the compositions micronizing with 15 parts of levamisole hydrochlorides, 10 parts of mixing for standby use of vitamin C.
Embodiment 2: 45 parts of the Radixs Astragali, mix for 10 parts with 15 parts of levamisole hydrochlorides, vitamin C after the high efficiency extraction, and add an amount of excipient, binding agent is processed granule.
Embodiment 3: 40 parts of the Radixs Astragali, add 15 parts of levamisole hydrochlorides, 15 parts of wiring solution-forming agent of vitamin C after the high efficiency extraction, and the 1ml medicinal liquid is equivalent to the 1g raw medicinal herbs.
Above embodiment has been merely the present invention has been further described, and scope of the present invention does not receive the limitation of the embodiment that lifts.
The part of test results report:
A kind of test report that contains the medical composition and its use of the Radix Astragali
Select for use certain to make a definite diagnosis 103 of pigletss in the pig farm of infecting swine fever, be divided into two groups of A, B at random.Stable breeding keeps clean, in time ventilates, and carries out record.Complete feedstuff is regularly raised, and freely drinks water unified management.The A group is added this extract (being produced jointly by the positive day pharmaceutcal corporation, Ltd of Guangdong Zijin, herbal medicine engineering and technological research development centre, Guangdong Province), converts water 300kg by 100ml and freely drinks; The B group is astragalin injection (antiviral I injection) (being provided by veterinary drug engineering and technological research development centre, Heyuan City), by per kilogram of body weight 0.1ml injection, one day twice.
Table 1 A, B group treatment comparative test result
Can find out that by table 1 used this kind to contain the sick pig of the combination treatment of the Radix Astragali, dead quantity obviously descended since the 3rd day; Feed intake is obviously recovered; Mental status just took a turn for the better after the medication in second day to some extent, four days basic end of medicine for treatment, and effect is superior to matched group.Therefore explain that this kind compositions can regulate immunologic function, strengthen premunition, reduce sickness rate, can be used for treating swine fever and infect.
Claims (3)
1. medical composition and its use that contains the Radix Astragali contains the derivant of the form of chemically can accepting of the Radix Astragali or Radix Astragali extract or Radix Astragali extract; The component and the prescription of compositions are: 100 parts of the Radixs Astragali, 1～50 part of levamisole hydrochloride.
2. a kind of medical composition and its use that contains the Radix Astragali according to claim 1 is characterized in that increasing by 20～150 parts of vitamin Cs.
3. a kind of medical composition and its use that contains the Radix Astragali according to claim 1 and 2; It is characterized in that said compositions method for using and use amount are: solid preparation uses later on by the mixed of complete feed 0.1～10.0%; Liquid preparation 100ml drinks after converting water 250kg～500kg, and the 1ml medicinal liquid is equivalent to the 1g raw medicinal herbs.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201110297559A CN102327315A (en) | 2011-09-29 | 2011-09-29 | Drug combination containing astragalus and use thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201110297559A CN102327315A (en) | 2011-09-29 | 2011-09-29 | Drug combination containing astragalus and use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102327315A true CN102327315A (en) | 2012-01-25 |
Family
ID=45479445
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201110297559A Pending CN102327315A (en) | 2011-09-29 | 2011-09-29 | Drug combination containing astragalus and use thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102327315A (en) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1850148A (en) * | 2006-05-19 | 2006-10-25 | 天津生机集团有限公司 | Medicine for increasing bird's immunity and treating immunity-inhibiting diseases, and preparing medicine therefor |
| CN101297815A (en) * | 2007-10-31 | 2008-11-05 | 天津生机集团有限公司 | Powder combined with Chinese medicament and western medicament for improving immunity of chicken and preparation thereof |
| CN101954078A (en) * | 2010-09-21 | 2011-01-26 | 江苏省农业科学院 | Vaccine adjuvant for swine enzootic pneumonia vaccine and preparation method and application thereof |
| CN101954079A (en) * | 2010-09-21 | 2011-01-26 | 江苏省农业科学院 | Vaccine adjuvant of swine mycoplasmal pneumonia live vaccine, and preparation method and application thereof |
-
2011
- 2011-09-29 CN CN201110297559A patent/CN102327315A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1850148A (en) * | 2006-05-19 | 2006-10-25 | 天津生机集团有限公司 | Medicine for increasing bird's immunity and treating immunity-inhibiting diseases, and preparing medicine therefor |
| CN101297815A (en) * | 2007-10-31 | 2008-11-05 | 天津生机集团有限公司 | Powder combined with Chinese medicament and western medicament for improving immunity of chicken and preparation thereof |
| CN101954078A (en) * | 2010-09-21 | 2011-01-26 | 江苏省农业科学院 | Vaccine adjuvant for swine enzootic pneumonia vaccine and preparation method and application thereof |
| CN101954079A (en) * | 2010-09-21 | 2011-01-26 | 江苏省农业科学院 | Vaccine adjuvant of swine mycoplasmal pneumonia live vaccine, and preparation method and application thereof |
Non-Patent Citations (6)
| Title |
|---|
| 《畜禽业》 20080930 任建明等 PRRSV变异株引发的猪"高热病"防控技术探讨 43-45 1-3 , 第233期 * |
| 任建明等: "PRRSV变异株引发的猪"高热病"防控技术探讨", 《畜禽业》, no. 233, 30 September 2008 (2008-09-30), pages 43 - 45 * |
| 武志勇: "黄芪素对鸡免疫力的影响", 《饲料广角》, no. 21, 10 November 2009 (2009-11-10), pages 48 - 49 * |
| 王凤霞等: "黄芪茎叶粉对雏鸡生长性能及免疫器官指数的影响", 《中国家禽》, vol. 31, no. 09, 5 May 2009 (2009-05-05), pages 53 - 54 * |
| 程忠刚等: "动物免疫增强剂的最新研究进展", 《今日养猪业》, no. 01, 28 February 2011 (2011-02-28), pages 17 - 22 * |
| 范开忠等: "当前猪无名高热病的有效防制措施", 《山东畜牧兽医》, vol. 29, no. 11, 15 November 2008 (2008-11-15), pages 64 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102908549B (en) | Preparation method of Chinese herbal medicine active fermentation health care liquid for preventing and treating bird flu | |
| CN100431581C (en) | Traditional Chinese medicine composition for treating fowl influenza, its preparation method and uses | |
| CN101698024B (en) | Traditional Chinese medicine for treating respiratory diseases and promoting growth for swine and preparation method thereof | |
| CN103127416B (en) | Drug for prevention and treatment of transmissible gastroenteritis of swine and epidemic diarrhea | |
| CN101297889B (en) | Chinese medicine preparation for treating foot-and-mouth disease and preparation method thereof | |
| CN104208163B (en) | It is a kind of improve animal immunizing power Chinese veterinary medicinal composition, using and preparation method thereof | |
| CN101698011B (en) | Medicine for treating epidemic diarrhea of livestock and poultry | |
| CN102552653A (en) | Traditional Chinese medicinal composition with phlegm reducing and cough relieving functions and preparation method thereof | |
| CN103784510A (en) | Chinese herbal medicine oral liquid for treating piglet diarrhea and production method thereof | |
| CN104739960A (en) | Intestine and stomach antibacterial drug composition, and intestine and stomach antibacterial drug containing intestine and stomach antibacterial drug composition and preparation thereof | |
| CN103285255A (en) | Anti-coccidiosis pharmaceutical composition as well as preparation method and use thereof | |
| CN101317879B (en) | Medicament for treating eperythrozoon diseases of cattle, sheep and pig | |
| CN101249097B (en) | Applications of ash tree flowers polysaccharide for preparing preventing and controlling pig virosis medicament | |
| CN104324153A (en) | Traditional Chinese medicine composition for improving immunity of animals and preparation method thereof | |
| CN101085037A (en) | Traditional Chinese medicine preparation for animals and preparation method thereof | |
| CN103142702A (en) | Chinese herbal medicine injection liquid for treating porcine reproductive and respiratory syndrome and preparation method thereof | |
| CN102327315A (en) | Drug combination containing astragalus and use thereof | |
| CN102327338A (en) | Rhubarb composition for treating chicken coccidiosis | |
| CN101972325A (en) | Medicament composition for treating chick coccidiosis and preparation method thereof | |
| CN101658587A (en) | Chinese materia medica preparation for treating bird bursal disease and preparation method thereof | |
| CN1899566A (en) | Medicine for preventing and controlling chicken's infectious rhinitis | |
| CN104208653A (en) | Traditional Chinese medicine composition for treating piglet yellow-white dysentery and preparation method for same | |
| CN104147399A (en) | Pharmaceutical preparation for swine fever | |
| CN115487250B (en) | Traditional Chinese medicine composition for preventing and treating African swine fever as well as preparation method and application thereof | |
| CN111544570B (en) | Antiviral preparation added with antibacterial peptide and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20120125 |